Leukotrienes (LTs) are potent bioactive lipids which have been conventionally viewed as paracrine mediators of inflammatory disease processes such as asthma [1] . More recent information suggests that they are also important participants in disease processes characterized by cellular proliferation and fibrogenesis [2] [3] [4] , and that they subserve a homeostatic role in antimicrobial host defense [5] . In view of the actions and importance of LTs, substantial effort over the last several years has been directed at increasing our understanding of their synthesis. Here I will provide a brief review of these recent advances in LT synthesis, with an emphasis on the biochemistry, molecular biology, and cell biology of the key enzymes involved. Certain unexpected findings which have emerged from these studies underscore the appropriateness of a perspective on LT biology which transcends conventional notions.
Leukotrienes (LTs) are potent bioactive lipids which have been conventionally viewed as paracrine mediators of inflammatory disease processes such as asthma [1] . More recent information suggests that they are also important participants in disease processes characterized by cellular proliferation and fibrogenesis [2] [3] [4] , and that they subserve a homeostatic role in antimicrobial host defense [5] . In view of the actions and importance of LTs, substantial effort over the last several years has been directed at increasing our understanding of their synthesis. Here I will provide a brief review of these recent advances in LT synthesis, with an emphasis on the biochemistry, molecular biology, and cell biology of the key enzymes involved. Certain unexpected findings which have emerged from these studies underscore the appropriateness of a perspective on LT biology which transcends conventional notions.
Overview of the leukotriene synthetic pathway
(see Fig. 1 )
Leukotriene synthesis can be triggered by a variety of soluble and particulate stimuli, including antigens, microbes, cytokines, immune complexes, and model agonists such as calcium ionophores. These result in the activation of signal transduction cascades and the generation of second messengers such as Ca 2þ , which in turn activate phospholipase A 2 (PLA 2 ). This enzyme initiates LT synthesis by catalysing the hydrolysis of arachidonic acid (AA) from membrane phospholipids. Although there are multiple isoforms of PLA 2 [6] , the most attractive candidate to subserve this function is cytosolic PLA 2 (cPLA 2 ), a Ca 2þ -dependent and AA-preferring 85 kDa enzyme.
The liberated free AA can then be acted on by the first committed enzyme in the LT synthetic pathway, 5-lipoxygenase (5-LO). This 78 kDa protein catalyses a twostep reaction: oxygenation of AA at carbon 5 to form an unstable intermediate, 5-hydroperoxyeicosatetraenoic acid (5-HPETE), followed by dehydration of 5-HPETE to the epoxide leukotriene A 4 (LTA 4 ). Maximal activity of 5-LO requires Ca 2þ , ATP, and hydroperoxide, and its efficient utilization of endogenously released AA in intact cells requires a 18 kDa helper protein, termed 5-LO activating protein (FLAP) [7] . FLAP is an AA-binding protein which is thought to optimally 'present' substrate to 5-LO. LTA 4 is the precursor for the stable bioactive LTs. It can be hydrolysed by LTA 4 hydrolase to LTB 4 , which has potent chemotactic and leucocyte-activating effects, or conjugated with reduced glutathione by LTC 4 synthase to yield LTC 4 ; LTC 4 can be further modified extracellularly by sequential amino acid removal to yield LTD 4 and LTE 4 . Collectively, LTC 4 , D 4 , and E 4 are known as the cysteinyl LTs, and comprise the smooth muscle contractile and vascular permeability activities long recognized as slow-reacting substance. Examination of this pathway thus identifies several critical proteins which are potential loci for regulation of LT synthesis, as will be discussed.
Cellular sources of leukotrienes
Phospholipase A 2 s, including cPLA 2 , are ubiquitously expressed among various cell types. However, 5-LO and FLAP proteins are largely restricted to cells of bone marrow origin (myeloid cells), and it is these cell types which have the greatest capacity for LT generation. Interestingly, the LT synthetic capacity of members of one family of myeloid cell, the resident tissue macrophage, varies in a tissuespecific fashion. In particular, pulmonary alveolar macrophages have a far greater LT synthetic capacity than do macrophages from other tissues [8] . In addition, the profile of LTs synthesized, which is dictated by a cell's complement of distal LT synthases, varies with the cell type. Thus, eosinophils and mast cells synthesize predominantly LTC 4 , while neutrophils synthesize predominantly LTB 4 . Macrophages synthesize a mixture of LTC 4 and LTB 4 , with differences depending primarily on species, e.g. rat and human macrophages produce predominantly LTB 4 , while murine macrophages produce predominantly LTC 4 .
Although the LT synthetic capacity of structural or parenchymal cells (epithelial cells, endothelial cells, fibroblasts, smooth muscle cells) is minuscule relative to myeloid cells, they can generate LTs under some circumstances. Importantly, studies with pharmacological inhibitors and antagonists in these cell types suggest that even these low levels of LTs can play important biological roles [9] [10] [11] . The distal LT synthase enzymes (LTA 4 hydrolase and LTC 4 synthase) are expressed somewhat more widely than are 5-LO and FLAP, being found in a variety of cell types which lack the latter. Parenchymal cells can also therefore contribute to LT production by converting LTA 4 released by myeloid cells to either LTB 4 or LTC 4 , a process known as 'transcellular' LT synthesis.
Regulation of leukotriene synthesis
Although LTs must be synthesized de novo, this can be accomplished quite rapidly (i.e. within several minutes) following addition of an agonist, via activation of enzymes which are constitutively present within cells. Activation of both cPLA 2 and 5-LO requires an increase in intracellular Ca 2þ , and the activity of 5-LO is optimized in the presence of ATP. Neither FLAP nor distal LT synthases depends on an 'activation' event, but LTC 4 synthase requires reduced glutathione as a cosubstrate. Thus, even the immediate generation of LTs can be influenced by the intracellular levels of the small molecules Ca 2þ , ATP, and glutathione.
The activities of the LT-synthesizing enzymes can be rapidly augmented by post-translational modifications such as phosphorylation. Phosphorylation of serine 505 on cPLA 2 , which occurs following the addition of a variety of 'priming' agents, increases the catalytic efficiency with which this enzyme causes hydrolysis of AA [12] . The actions of 5-LO also appear to be augmented by kinase activation [13] , and there is some evidence for direct phosphorylation of 5-LO [14] .
A delayed type of priming or enhancement of LT synthesis occurs with transcriptional or translational events which increase the steady-state level of key enzyme proteins. This phenomenon has been observed for cPLA 2 as well as another Ca 2þ -dependent enzyme, secretory PLA 2 . It has also been observed for 5-LO and FLAP, and the regulation of expression of these two proteins will be briefly considered here. The promoter region of the 5-LO gene resembles that of 'housekeeping' genes, in that only a few cis-acting elements are present [15] . This is surprising given the restricted cellular and tissue distribution of the encoded protein. Polymorphisms of the 5-LO promoter have recently been described, with mutations resulting in reduced transcription being noted in Ϸ 35% of individuals [16] ; it remains to be determined whether these mutations are associated with diminished LT production, or have clinical relevance. In contrast to that for 5-LO, the promoter region of the FLAP gene has multiple regulatory elements [17] . In most experimental systems, FLAP expression is regulated concordantly with 5-LO expression [18] , although examples of discordant expression have been described [19] . Despite differences in their promoter structures, expression of both proteins has been reported to be upregulated by similar experimental variables; these include various cytokines, glucocorticoids, and models of macrophage differentiation. It is important to note that the regulatory effects of a given agent can vary depending on the cell type. For example, granulocyte-macrophage colony stimulating factor increases the expression of both 5-LO and FLAP proteins in neutrophils [20] , but increases only the expression of cPLA 2 in macrophages [21] . Finally, reduced expression of 5-LO and FLAP has been reported in alveolar macrophages obtained from patients infected with the human immunodeficiency virus [22] .
In addition to the concentrations of small molecule cofactors, the steady state levels of key proteins, and modifications that alter the catalytic activities of these proteins, one further determinant of LT synthesis has recently been recognized: the intracellular compartmentalization of LT-synthesizing proteins. This has been the focus of extensive investigation in our own and other laboratories in recent years, and a number of surprising findings have been revealed. The remainder of this review will focus on the current state of knowledge in this area.
The translocation model for 5-lipoxygenase activation
The intracellular locale of the proteins necessary for LT synthesis went largely unstudied for many years. An important advance in our understanding of the mechanism of 5-LO activation was the demonstration that the enzyme undergoes a Ca 2þ -dependent redistribution or translocation from its locale within a soluble intracellular compartment in resting cells to a membrane compartment following agonist activation [23] . This process of translocation could reasonably be assumed to bring the enzyme in proximity to its membrane-derived substrate. It was soon determined that cPLA 2 likewise underwent a Ca 2þ -dependent redistribution from a soluble to a membrane compartment upon stimulation [24] . Since the helper protein FLAP was also present in the membrane fraction of cells both in the resting and stimulated states [7] , a model was formulated in which agonist activation resulted in colocalization of the proteins necessary for arachidonate release and the initiation of LT synthesis. Since LTs were known to be efficiently secreted from cells, the site at which these proteins were colocalized was assumed to be the plasma membrane. However, these early subcellular fractionation studies were not capable of adequately resolving compartmentalization, and there was no a priori reason to do so at the time given the assumptions regarding the primacy of the plasma membrane.
Role of the nuclear envelope in leukotriene synthesis (see Fig. 2 ) Surprisingly, when activated blood neutrophils were studied by immunoelectron microscopy, both 5-LO and FLAP were localized to the nuclear envelope [25] . At about the same time, peritoneal macrophages were gently disrupted (so that the plasma membrane but not the nuclear membrane was ruptured) and separated into nuclear, cytosolic, and non-nuclear membrane fractions which were then subjected to immunoblot analysis. FLAP was found predominantly in the nuclear fraction of both resting and stimulated cells; furthermore, 5-LO was found to translocate from the cytosolic to the nuclear fraction upon activation [26] . These results indicating the nuclear envelope to be the site of 5-LO and FLAP colocalization in activated leucocytes appear to reflect a universal phenomenon, now also verified for alveolar macrophages [27, 28] , blood monocytes [27] , mast cells [29] , and the rat basophilic leukaemia (RBL) mast cell-like cell line [28] . Localization of 5-LO at the nuclear envelope in activated cells has now also been confirmed in situ, since immunohistochemical analysis revealed an increased number of macrophages with this staining pattern in lung sections from patients with both idiopathic pulmonary fibrosis [3] and primary pulmonary hypertension [4] , diseases characterized by constitutive overproduction of LTs.
Of course, these findings with 5-LO and FLAP raised the question of whether cPLA 2 translocated to the same membrane. Recent studies using appropriate disruption and fractionation methods as well as immunofluorescence microscopy have indeed revealed that cPLA 2 is also localized primarily at the nuclear envelope in a variety of types of stimulated cells [26, 30, 31] . Importantly, translocation of cPLA 2 to the nuclear envelope has been shown to be associated with selective hydrolysis of nuclear membrane phospholipids [30] . Recently, LTC 4 synthase has been shown to have a high degree of homology with FLAP; like FLAP, it too is an integral membrane protein located primarily at the nuclear envelope [32] . Taken together, there is now abundant evidence suggesting that the nuclear envelope is the site at which AA release (at least that mediated by cPLA 2 ), LTA 4 synthesis, and LTA 4 conversion to LTC 4 all occur. The mechanism by which the translocation of cPLA 2 and 5-LO which originate in the cytosol is targeted to the nuclear envelope, as opposed to other intracellular membranes, remains to be elucidated. In any case, these findings raise the important question of why mediators destined for extracellular secretion would be synthesized deep within the cell, and this will be considered at the end of this communication.
Cell-specific compartmentalization of 5-lipoxygenase in resting cells
(see Fig. 2 )
Initial studies in unstimulated blood neutrophils [33] and peritoneal macrophages [26] demonstrated that 5-LO was predominantly cytosolic, and this finding has been extended to blood monocytes [27] . Unexpectedly, subsequent fractionation as well as immunomicroscopic studies of isolated alveolar macrophages [27, 28] , mast cell-like RBL cells [33] , and primary mast cells [29] revealed abundant intranuclear 5-LO in addition to that found within the cytosol. Importantly, an intranuclear pool of 5-LO in alveolar macrophages has been confirmed in situ by immunohistochemical staining of normal human lung tissue [3] . A portion of the intranuclear pool in RBL cells is insoluble and has biochemical characteristics suggesting that it is chromatin-associated [33] . Immunoelectron microscopic analysis of human alveolar macrophages demonstrated that intranuclear 5-LO was not randomly distributed, but was instead concentrated in the euchromatin region [27] , that portion of the nucleus where actively transcribing genes are distributed. That the intranuclear pool of 5-LO participates in cellular LT synthesis is suggested by the facts that it is catalytically active in cell-free assays and translocates to the nuclear envelope upon agonist stimulation [28] . These findings indicate that compartmentalization of 5-LO in unstimulated cells varies depending on the cell type, with some cells exhibiting exclusively cytosolic enzyme and others containing both cytosolic and intranuclear pools; in either case, activation is associated with translocation to the nuclear envelope. The mechanisms by which compartmentalization of 5-LO is differentially regulated in different cell types are not currently understood.
Dynamic regulation of 5-lipoxygenase compartmentalization
Rather than a static model in which 5-LO compartmentalization is considered to be dictated solely by cell type, several lines of evidence indicate that it is, in fact, a dynamically regulated process even within a given cell type. The first is based on data obtained with various mononuclear phagocyte populations. Blood monocytes, the precursors for all mature tissue macrophages, contain cytosolic 5-LO [27] . While mature peritoneal macrophages retain this cytosolic distribution [26] , alveolar macrophages do not [27, 28] , indicating that nuclear import of this protein accompanies monocyte migration into the pulmonary alveolar space, but not the peritoneum. Second, the recruitment of blood neutrophils into sites of inflammation (either pulmonary alveolus or peritoneum) is associated with rapid movement of 5-LO into the nucleus, which is not itself accompanied by LT synthesis [34] . This can be mimicked by adherence of blood neutrophils to various surfaces [34] . A final example involves DMSO-induced differentiation of the promyelocytic leukaemic cell line, HL-60, into granulocytic cells, a process previously recognized [35] to be associated with increased expression of both 5-LO and FLAP. We have observed that incubation of these cells with serum results in a shift of 5-LO localization from the cytosol to the intranuclear compartment (unpublished results). Again, the molecular mechanisms by which dynamic nuclear import of 5-LO is mediated are as yet undefined. However, it is interesting that experimental conditions in which nuclear import of both cPLA 2 [36] and cyclo-oxygenase-2 [37] , an inducible form of the enzyme responsible for conversion of AA to prostaglandins, have recently been described. Thus, the phenomenon of dynamic modulation of 5-LO compartmentalization may serve as a model which also applies to other enzymes in the eicosanoid synthetic pathway.
Metabolic implications of 5-lipoxygenase localization
The fact that 5-LO and FLAP (along with other relevant proteins) are localized to the nuclear envelope of activated cells implies that LT synthesis is initiated at this site. As a result, the local concentrations of LTs within the nucleus are likely to be quite high. Teleologically, these observations strongly suggest that the potential nuclear actions of these bioactive lipid mediators may be more important than those extracellular actions which have been classically recognized. Indeed, a growing body of evidence implicates endogenously produced 5-LO metabolites as modulators of such fundamental processes as mitogenesis [11] , apoptosis [2, 38] , and the expression or activation of various transcription factors including NF k B [10, 39, 40] and fos [11] . Theoretically, these actions of LTs could involve their direct interaction with nucleic acids, transcription factors, or signalling pathways. The recent identification of a nuclear receptor for LTB 4 exemplifies such a direct intranuclear interaction [41] ; interestingly, this receptor was a member of the steroid superfamily of transcription factors and its ligation was capable of inducing gene transcription. Finally, it should also be recalled that reactive oxygen species are a byproduct of arachidonate 5-lipoxygenation, and these reactive intermediates could themselves possess nuclear actions by activating transcription factors or otherwise modifying nuclear constituents. 5-LO-dependent activation of NF k B has been ascribed to reactive oxygen species in some [39, 40] but not all [10] experimental systems. The propensity of particular LT-forming proteins to be localized at particular intracellular sites raises the possibility that metabolic coupling among proteins will be dictated by their topographic proximity. This notion posits that both the access of 5-LO/FLAP to free AA and their capacity to supply LTA 4 for LT synthesis will be enhanced by the proximity of PLA 2 and LT synthases, respectively, to the nuclear envelope. In this regard, it has long been recognized that different functional pools of AA exist within a given cell type, and different metabolic fates for AA could reflect the topographic proximity of PLA 2 s and downstream enzymes.
Dynamic nuclear import of 5-LO adds a further measure of complexity to the regulation of LT synthesis. It should be emphasized that nuclear import is not itself associated with LT synthesis. But how does this phenomenon in resting cells influence subsequent LT generation upon activation? In two different experimental models (peritoneal vs alveolar macrophages and blood vs. recruited neutrophils), the latter cells with intranuclear 5-LO require a higher dose of ionophore to trigger LT synthesis than do the former cells with cytosolic enzyme [8, 34] . This could reflect the likelihood that intranuclear Ca 2þ concentrations are lower than cytosolic Ca 2þ concentrations following the addition of an extracellular stimulus. However, alveolar macrophages [8] , recruited neutrophils [34] , and serum-treated differentiated HL-60 cells (unpublished results) (all with intranuclear 5-LO) all display greater maximal capacities for LT production in response to stimuli than do the corresponding cells with cytosolic 5-LO. The lower sensitivity and greater capacity of these cells with an intranuclear distribution of 5-LO could alternatively reflect a lower hydroperoxide tone in the nuclear than cytosolic compartment. In any case, a growing body of evidence indicates that compartmentalization of 5-LO is an important determinant of LT synthetic responses.
Non-metabolic implications of 5-lipoxygenase localization
The localization of 5-LO could have biological implications which go beyond its catalytic products, LTs and reactive oxygen species. The 5-LO protein has a Src homology-3 binding motif [42] , which could mediate protein-protein interactions between the enzyme and Src homology-3 domains. These domains are typically present in proteins which are substrates for tyrosine phosphorylation, and purified 5-LO has been shown to bind with certain cytoskeletal proteins [42] . This motif on 5-LO has been suggested to mediate enzyme translocation in response to activation [14] . The facts that 5-LO can be found within the euchromatin region of nuclei and can be demonstrated to be chromatin-associated further suggest that the enzyme could likewise interact directly with intranuclear proteins or, perhaps, genes.
Conclusions
Our understanding of the molecular mechanisms and regulation of LT synthesis has increased dramatically in recent years. In particular, investigations into the cell biology of this metabolic pathway have revealed an unexpected role for the nucleus. While many questions of a molecular and functional nature remain to be answered, this finding provides the impetus to explore novel intracellular actions of LTs beyond those traditionally appreciated.
